Related Experiment Video
Updated: May 31, 2026

Developing a Clinically Relevant Hemorrhagic Shock Model in Rats
Published on: March 22, 2024
Differential propensity for major hemorrhagic events in patients with different types of arterial disease
S Achterberg1, F L J Visseren, L J Kappelle
1Department of Neurology, Utrecht Stroke Center, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, the Netherlands. s.achterberg-2@umcutrecht.nl
Insights
Patients with cerebrovascular disease (CVD) or peripheral arterial obstructive disease (PAD) face a higher risk of major bleeding events than those with coronary artery disease (CAD). This increased risk is not explained by common risk factors or genetic variations.
Area of Science:
- Cardiovascular Medicine
- Hemorrhagic Complications
- Atherosclerosis Research
Background:
- Atherosclerosis is a primary cause of coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral arterial obstructive disease (PAD).
- Previous findings indicated a two-fold higher risk of major hemorrhagic complications in patients with CVD or PAD compared to those with CAD.
Purpose of the Study:
- To investigate whether the elevated risk of major hemorrhagic complications in CVD/PAD patients versus CAD patients is due to baseline risk factors or genetic variants in hemostasis.
- To identify the underlying causes for differential bleeding risks among atherosclerosis subtypes.
Main Methods:
- A cohort of 2622 patients with non-disabling CAD, CVD, or PAD was followed for a mean of 6.6 years.
- Major hemorrhagic complications, including intracranial, fatal, and hospitalization-requiring events, were recorded.
- Statistical analysis included hazard ratios adjusted for baseline characteristics and genetic variants.
Main Results:
- Major hemorrhagic complications occurred in 122 patients (0.77% annual event rate).
- Patients with CVD or PAD exhibited a significantly higher risk of major hemorrhagic complications compared to CAD patients (HR 2.05).
- This disparity was not explained by hypertension, diabetes, renal failure, antithrombotic use, or genetic variants.
Conclusions:
- Patients with CVD or PAD have a substantially higher risk of major hemorrhagic events than those with CAD.
- Known risk factors, antithrombotic therapies, and genetic hemostasis variants do not account for this observed difference.
- Further research is essential to elucidate the reasons behind this risk differential and explore potential variations in pathogenesis.
Aims:
Atherosclerosis is the most frequent cause of coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral arterial obstructive disease (PAD). We previously found that patients with CVD or PAD had a two-fold higher risk of major hemorrhagic complications than patients with CAD. We investigated whether this difference was attributable to baseline risk factors or genetic variants involved in hemostasis.
Methods And Results:
We included 2622 consecutive patients from a single university hospital who presented with non-disabling CAD, CVD, or PAD. All patients were followed for the occurrence of major hemorrhagic complications for a mean of 6.6 years. Major hemorrhagic events included intracranial hemorrhagic events, fatal hemorrhagic events, and any hemorrhagic complications requiring hospitalization, irrespective of interventions. Major hemorrhagic complications occurred in 122 patients (annual event rate of 0.77%). Patients with CVD or PAD had more hemorrhagic complications than patients with CAD (hazard ratio [HR] 2.05, 95% confidence interval [CI] 1.39-3.01). Hypertension, diabetes, renal failure and use of oral anticoagulants or antiplatelet therapy did not explain the difference (HR adjusted for all characteristics 1.74; 95% CI 1.14-2.61). Additional adjustment for genetic variants did not further change the HR.
Conclusion:
Patients with CVD or PAD are at higher risk for major hemorrhagic events than patients with CAD. This difference could not be explained by known risk factors, use of antithrombotic agents, or genetic variants involved in hemostasis. Further research to find the reason for this difference and possible differences in pathogenesis is warranted.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Stroke: Introduction and Types
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

